Sanara MedTech Inc. (ticker: SMTI) is an NASDAQ-listed orthopedic, prosthetic & surgical appliances & supplies company. DredgeCap's structured extraction of SMTI's SEC filings surfaces 41 active risk signals, including 40 late-filing signals, and 1 auditor-change signal. SMTI reported $27.80M in revenue and $459K for the period ending 2026-03-31, with operating cash flow of -$2.47M. Cash and equivalents stood at $13.59M (down 34.3% year-over-year). Total assets of $69.28M exceed total liabilities of $62.26M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
SMTI SEC Filings
Full cached SEC EDGAR filing history for SMTI, grouped by form type and sorted newest-first within each group. 0 filings across 0 form types.
Filings sourced verbatim from SEC EDGAR submissions metadata. “Structured” links route to DredgeCap's per-filing renderer (XBRL-backed financials + cited highlights) when available; the EDGAR link always points to the canonical accession index on sec.gov.